Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The first meta-analysis to examine hep C treatment outcomes in seniors versus non-seniors found that cure rates are comparable.
Kaiser Health News takes an in-depth look.
Health advocate David Whiters has mastered some smooth moves since overcoming addiction and hep C.
Currently, there are no pharmacological treatments for liver fibrosis related to non-alcoholic steatohepatitis.
A roundup of POZ’s reporting on studies presented at the Mexico City conference about HIV treatment, vaccines, PrEP and other concerns.
Better treatments for hepatitis B and C and a lack of such advances for fatty liver or alcoholic liver disease are driving outcomes.
A meta-analysis has helped clear up conflicting previous evidence regarding this association.
Las Vegas resident Stella Armstrong cured her hep C and the joy-killing fatigue and pain that came with it.
A new systematic review and meta-analysis indicates that hepatitis C is most notably also associated with B-cell non–Hodgkin lymphoma.
A quick overview of our reporting on the 53rd International Liver Congress in Vienna
Recent research shows about 1 in 4 people in the United States have fatty liver disease. Among Latinos, the rate is significantly higher.
A look at the supply chain that results in very high costs for HIV and hepatitis C medications.
Indianapolis native Matt Heskett beat both opioid addiction and hep C. Now he’s paying his good fortune forward with activism and education.
Researchers reviewed numerous studies to inform their detailed tips for better engaging people who inject opioid drugs in hepatitis C care.
Scientists have firmly established an association between direct-acting antiviral treatment and a lower risk of liver cancer and death.
A look at modifiable risk factors that drive non-AIDS cancers, heart attack and end-stage liver and kidney disease in the HIV population
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.